XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,040,952 | +1357.4% | 1,084,337 | +1542.5% | 0.02% | +1500.0% |
Q2 2023 | $2,541,616 | -34.2% | 66,016 | -38.9% | 0.00% | -50.0% |
Q1 2023 | $3,863,960 | +72.4% | 107,962 | +90.0% | 0.00% | +100.0% |
Q4 2022 | $2,241,004 | -56.5% | 56,835 | -60.2% | 0.00% | -50.0% |
Q3 2022 | $5,152,000 | -60.6% | 142,726 | -66.8% | 0.00% | -66.7% |
Q2 2022 | $13,079,000 | +13.6% | 429,960 | +14.2% | 0.01% | +50.0% |
Q1 2022 | $11,514,000 | +25.3% | 376,651 | +28.1% | 0.00% | +33.3% |
Q4 2021 | $9,188,000 | +128.6% | 294,098 | +11.8% | 0.00% | +50.0% |
Q3 2021 | $4,020,000 | +983.6% | 263,103 | +1221.6% | 0.00% | – |
Q2 2021 | $371,000 | – | 19,908 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |